noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

University of Hawai?i at Manoa

Rare, deep-sea goblin shark observed in natural habitat
Martin Heinrich

Heinrich, Luján Demand Answers from Secretary Burgum on Taxpayer[...]
Arista Networks Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Healthcare

Ironwood Pharmaceuticals Inc.

06/15/2026 | Press release | Distributed by Public on 06/15/2026 14:06

Material Event (Form 8-K)

Item 8.01 Other Events.

On June 15, 2026, Ironwood Pharmaceuticals, Inc. (the "Company") repaid in full the $200.0 million aggregate principal amount of its 1.50% convertible senior notes due 2026 (the "2026 Convertible Notes") at their scheduled maturity. The Company funded the repayment of the outstanding aggregate principal amount of the 2026 Convertible Notes using proceeds from available cash on hand. No conversions were exercised by holders of the 2026 Convertible Notes, and the capped call transactions the Company has separately entered into in connection with the issuance of the 2026 Convertible Notes terminated upon expiry.

Ironwood Pharmaceuticals Inc. published this content on June 15, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 15, 2026 at 20:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]